Treatment of Buccal Ginvigal Recessions With the Tunnel Technique in Conjunction With Cross-linked Hyaluronic Acid and Subepithelial Connective Tissue Graft. A Randomized Clinical Trial

NCT ID: NCT05436002

Last Updated: 2022-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-15

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the outcomes of buccal gengival recession type 1 (RT1) treated with the tunnel technique in conjunction with a cross-linked hyaluronic acid and subepithelial palatal connective tissue grafts.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate the outcomes of buccal gengival recession type 1 (RT1) treated with the tunnel technique in conjunction with a cross-linked hyaluronic acid and subepithelial palatal connective tissue grafts.

To evaluate the esthetic outcome as perceived by periodontists, using the root coverage esthetic score (RES).

Test Group - Tunnel technique in conjunction with a cross-linked hyaluronic acid and subepithelial palatal connective tissue grafts.

Control Group - Tunnel technique and subepithelial palatal connective tissue grafts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cross-linked Hyaluronic Acid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Cross-linked Hyaluronic Acid

Tunnel Technique in Conjunction With Cross-linked Hyaluronic Acid and Subepithelial Connective Tissue Graft.

Group Type ACTIVE_COMPARATOR

With Cross-linked Hyaluronic Acid

Intervention Type DEVICE

Without Cross-linked Hyaluronic Acid

Whitout Cross-linked Hyaluronic Acid

Tunnel Technique in Conjunction With Subepithelial Connective Tissue Graft.

Group Type PLACEBO_COMPARATOR

With Cross-linked Hyaluronic Acid

Intervention Type DEVICE

Without Cross-linked Hyaluronic Acid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

With Cross-linked Hyaluronic Acid

Without Cross-linked Hyaluronic Acid

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* None of the patients were smokers and all were systemically healthy without any signs of periodontal disease.
* Each patient had to display at least one ginvigal recession (RT1) of a depth of ≥ 2 mm.
* Patients exhibited an adequate level of oral hygiene evidenced by a full- mouth plaque score (FMPS) \< 25%39 and full-mouth bleeding score (FMBS) \< 25%.

Exclusion Criteria

* Smokers
* Gingival recesstion RT 2 or RT 3 (Cairo 2011).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lisbon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vanessa Rocha Rodrigues

Dra

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vanessa Rodrigues, Dr

Role: PRINCIPAL_INVESTIGATOR

University of Lisbon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vanessa Rodrigues, Dr

Role: CONTACT

919950890 ext. +351

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cross-linked hyaluronic acid

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.